We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.05B
AUM Growth
+$259M
Cap. Flow
+$4.36M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.09%
Holding
255
New
12
Increased
112
Reduced
101
Closed
15

Top Buys

Rank Stock Value
1
OSK icon
Oshkosh
OSK
+$14.9M
2
UPWK icon
Upwork
UPWK
+$13.9M
3
TTI icon
TETRA Technologies
TTI
+$10.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$8.64M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.86M

Top Sells

Rank Stock Value
1
AEHR icon
Aehr Test Systems
AEHR
+$16.9M
2
FN icon
Fabrinet
FN
+$11.8M
3
CEVA icon
CEVA Inc
CEVA
+$11.4M
4
FOLD
Amicus Therapeutics
FOLD
+$11.1M
5
GTLS
Chart Industries
GTLS
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.48%
2 Technology 28.09%
3 Industrials 14.98%
4 Consumer Discretionary 7.96%
5 Communication Services 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPWK icon
26
Upwork
UPWK
$1.08B
$23.2M 1.13%
2,776,805
+1,468,638
+112% +$13.9M
G icon
27
Genpact
G
$6.03B
$22.9M 1.12%
833,996
+129,872
+18% +$4.27M
SUPN icon
28
Supernus Pharmaceuticals
SUPN
$2.4B
$22.8M 1.11%
490,221
+12,805
+3% +$615K
VRDN icon
29
Viridian Therapeutics
VRDN
$2.47B
$21.6M 1.05%
1,175,906
+277,295
+31% +$4.47M
RDWR icon
30
Radware
RDWR
$1.25B
$21M 1.02%
680,853
-2,410
-0.4% -$66.7K
ALKS icon
31
Alkermes
ALKS
$7.72B
$20.5M 1%
390,866
+522
+0.1% +$20.4K
NEXN
32
Nexxen International
NEXN
$527M
$19.7M 0.96%
2,186,838
+69,426
+3% +$548K
PRGS icon
33
Progress Software
PRGS
$1.79B
$19.1M 0.93%
570,261
+117,559
+26% +$3.48M
QDEL icon
34
QuidelOrtho
QDEL
$729M
$18.6M 0.91%
1,063,559
+37,139
+4% +$491K
LMAT icon
35
LeMaitre Vascular
LMAT
$1.84B
$18.2M 0.89%
189,907
+5,182
+3% +$531K
EEFT icon
36
Euronet Worldwide
EEFT
$2.62B
$18.1M 0.88%
247,689
+5,698
+2% +$398K
LKQ icon
37
LKQ Corp
LKQ
$5.92B
$17.9M 0.87%
678,259
-6,893
-1% -$192K
WIX icon
38
WIX.com
WIX
$3.46B
$17.4M 0.84%
382,619
+85,832
+29% +$5.31M
NBIX icon
39
Neurocrine Biosciences
NBIX
$15.2B
$16.9M 0.82%
100,195
+205
+0.2% +$30.4K
HROW icon
40
Harrow
HROW
$1.27B
$16.5M 0.8%
387,545
+19,368
+5% +$720K
OSK icon
41
Oshkosh
OSK
$8.84B
$16.3M 0.79%
+106,011
New +$14.9M
MTN icon
42
Vail Resorts
MTN
$4.92B
$15.9M 0.78%
117,085
+292
+0.3% +$38K
ACAD icon
43
Acadia Pharmaceuticals
ACAD
$4.61B
$15.7M 0.76%
618,887
+1,398
+0.2% +$30.8K
LCII icon
44
LCI Industries
LCII
$2.13B
$15.1M 0.74%
142,665
+37,322
+35% +$4.1M
VREX icon
45
Varex Imaging
VREX
$778M
$15.1M 0.73%
1,445,853
+171,035
+13% +$1.85M
MMS icon
46
Maximus
MMS
$3.05B
$15M 0.73%
278,910
+55,986
+25% +$3.49M
BMRN icon
47
BioMarin Pharmaceuticals
BMRN
$12.5B
$14.2M 0.69%
248,224
+143,565
+137% +$7.86M
TSHA icon
48
Taysha Gene Therapies
TSHA
$1.65B
$13.6M 0.66%
1,992,229
+47,558
+2% +$281K
OZK icon
49
Bank OZK
OZK
$5.36B
$13.5M 0.66%
259,433
-160
-0.1% -$7.79K
MIRM icon
50
Mirum Pharmaceuticals
MIRM
$6.1B
$13M 0.63%
110,673
-36,364
-25% -$3.65M
1
2
3 4 5

Similar funds

ABTD
Arvest Bank Trust Division Dewey, Oklahoma $2.05B AUM 30.62% 1-Year Est. Return
CFA
Capstone Financial Advisors Downers Grove, Illinois $2.05B AUM 19.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $2.05B AUM 30.99% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $2.05B AUM 4.29% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $2.05B AUM 0.32% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return

Rice Hall James & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Rice Hall James & Associates held 255 positions worth $2.05B, up 14% from $1.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q2 2026 filing shows 12 new, 112 increased, 101 reduced and 15 closed positions. Its largest new stake was Oshkosh: 106,011 shares worth $16.3M. The largest sale was Aehr Test Systems, an estimated $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q2 2026 buy was Oshkosh: 106,011 shares worth $16.3M.
  • Rice Hall James & Associates added most to Upwork in Q2 2026, an estimated $13.9M increase.
  • Rice Hall James & Associates's biggest Q2 2026 reduction was Aehr Test Systems, cutting an estimated $16.9M.
  • Rice Hall James & Associates fully exited Amicus Therapeutics in Q2 2026, selling an estimated $11.1M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.05B portfolio in Q2 2026.
  • Rice Hall James & Associates opened 12 new positions and closed 15 in Q2 2026.
  • Rice Hall James & Associates's portfolio value rose 14% quarter-over-quarter to $2.05B.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.